Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2007
-
By Kevin E. Noonan — Gene Quinn from the PLI blog reports today that Judge Cacheris denied from the bench Plaintiffs’ motion for discovery in the challenge to the claims and continuation rules enjoined by the Court on October 31st (see "Tafas v. Dudas; SmithKline Beecham Corp. v. Dudas (E.D. Va. 2007)"). Patent…
-
By Donald Zuhn — Alnylam Pharmaceuticals, Inc. announced today that it has received a German patent (DE 10080167) in the "Kreutzer-Limmer I" patent series. According to the Cambridge, Massachusetts-based RNA interference (RNAi) therapeutics company, the Kreutzer-Limmer I patent series is one of three "fundamental patent" families that Alnylam has exclusively licensed and which…
-
By Baltazar Gomez — Last month, Astellas Pharma Inc., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. Patent Nos. 5,731,296 and 5,070,877. The lawsuits involving the ‘296 and ‘877 patents were filed…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Abbott Laboratories v. Banner Pharmacaps Inc.1:07-cv-00754; filed November 21, 2007 in the District Court of Delaware Infringement of U.S. Patent Nos. 4,988,731…
-
December 3, 2007 – 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice – PTO Day (Intellectual Property Owners Association and U.S. Patent and Trademark Office) – Washington, D.C. December 13, 2007 – Pharmaceutical and Biotech Patent Law: Recent Developments (Practising Law Institute) January 9, 2008 – Patent Claim Construction (Law Seminars…
-
The authors and contributors of Patent Docs wish their readers a Happy Thanksgiving. Publication of Patent Docs will resume on November 25th.
-
A Reason for Thanksgiving By Kevin E. Noonan — Patent law is no longer the backwater it resembled prior to the creation of the Federal Circuit, but it rarely receives the limelight of national attention. Until recently, that is, when it seems every editorial and pundit is weighing in on how "broken" the…
-
By Donald Zuhn — Last week, Avicena Group, Inc. announced that it had been granted U.S. Patent No. 7,285,573. The ‘573 patent, which relates to use of creatine (lower left) and creatine phosphate (lower right) for treating amyotropic lateral sclerosis (ALS) or "Lou Gehrig’s Disease," is the fifth U.S. patent to be awarded…
-
Earlier this month, we reported that the Intellectual Property Owners Association (IPO) and the U.S. Patent and Trademark Office would be co-sponsoring the 18th Annual Conference on U.S. Patent and Trademark Office Law and Practice (PTO Day) on December 3, 2007 in Washington, D.C. At the time, we stated that it would be interesting to…
-
By Kevin E. Noonan — Let’s put our cards on the table. The zeitgeist in the patent world these days is that the U.S. Patent and Trademark Office engaged in a frenzy of granting "bad" patents over the past few years, and that the issue of patent "quality" has caused a crisis in…
Patent Docs 